Skip to main content
Premium Trial:

Request an Annual Quote

Xenometrix Receives Investment Funding

Premium

BOULDER, Colo.--Xenometrix, a biotech firm here with proprietary gene expression profiling technology and genotoxicology technology, received a cash infusion that the company said it expects will meet its operating requirements for two months. The infusion is the result of a letter of intent regarding a license for recently announced European patents and a US application and patents in the field of probe arrays.

The patents and application broadly cover methods and kits for producing gene expression profiles by exposing cells to pharmaceutical compounds and other chemicals, and then determining levels of expression of multiple genes in the cells. The company said these methods can be used by pharmaceutical and biotechnology companies to test compounds for efficacy and safety.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.